FINANCIERE DE TUBIZE (TUB.BR) Stock Price, Forecast & Analysis

EBR:TUB • BE0003823409

236.5 EUR
-1.5 (-0.63%)
Last: Feb 16, 2026, 10:11 AM

TUB.BR Key Statistics, Chart & Performance

Key Statistics
Market Cap10.53B
Revenue(TTM)N/A
Net Income(TTM)92.74M
Shares44.51M
Float19.19M
52 Week High241
52 Week Low102.8
Yearly Dividend0.97
Dividend Yield0.31%
EPS(TTM)2.08
PE113.7
Fwd PEN/A
Earnings (Next)03-21
IPO1987-01-02
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
TUB.BR short term performance overview.The bars show the price performance of TUB.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

TUB.BR long term performance overview.The bars show the price performance of TUB.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of TUB.BR is 236.5 EUR. In the past month the price increased by 1.06%. In the past year, price increased by 62.35%.

FINANCIERE DE TUBIZE / TUB Daily stock chart

TUB.BR Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to TUB.BR. When comparing the yearly performance of all stocks, TUB.BR is one of the better performing stocks in the market, outperforming 93.65% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
TUB.BR Full Technical Analysis Report

TUB.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR. While TUB.BR has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TUB.BR Full Fundamental Analysis Report

TUB.BR Financial Highlights

Over the last trailing twelve months TUB.BR reported a non-GAAP Earnings per Share(EPS) of 2.08. The EPS increased by 3.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 4.79%
ROE 4.79%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%2.84%
Sales Q2Q%N/A
EPS 1Y (TTM)3.02%
Revenue 1Y (TTM)N/A
TUB.BR financials

TUB.BR Forecast & Estimates

6 analysts have analysed TUB.BR and the average price target is 235.11 EUR. This implies a price decrease of -0.59% is expected in the next year compared to the current price of 236.5.


Analysts
Analysts76.67
Price Target235.11 (-0.59%)
EPS Next YN/A
Revenue Next YearN/A
TUB.BR Analyst EstimatesTUB.BR Analyst Ratings

TUB.BR Ownership

Ownership
Inst Owners5.22%
Ins Owners33.27%
Short Float %N/A
Short RatioN/A
TUB.BR Ownership

About TUB.BR

Company Profile

TUB logo image Financiere de Tubize SA is a holding company, which engages in investing in the biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The firm promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.

Company Info

FINANCIERE DE TUBIZE

Allee de la Recherche, 60

Brussels BRUXELLES-CAPITALE BE

Employees: 3

TUB Company Website

TUB Investor Relations

Phone: 320497515208

FINANCIERE DE TUBIZE / TUB.BR FAQ

What does TUB do?

Financiere de Tubize SA is a holding company, which engages in investing in the biopharmaceuticals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The firm holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The firm promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.


What is the stock price of FINANCIERE DE TUBIZE today?

The current stock price of TUB.BR is 236.5 EUR. The price decreased by -0.63% in the last trading session.


Does FINANCIERE DE TUBIZE pay dividends?

FINANCIERE DE TUBIZE (TUB.BR) has a dividend yield of 0.31%. The yearly dividend amount is currently 0.97.


What is the ChartMill technical and fundamental rating of TUB stock?

TUB.BR has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the analyst forecast for TUB.BR stock?

6 analysts have analysed TUB.BR and the average price target is 235.11 EUR. This implies a price decrease of -0.59% is expected in the next year compared to the current price of 236.5.


What is the market capitalization of TUB stock?

FINANCIERE DE TUBIZE (TUB.BR) has a market capitalization of 10.53B EUR. This makes TUB.BR a Large Cap stock.